Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novartis Sverige Aktiebolag
AB
Active
Org 5560533092
Torshamnsgatan 48, 164 40
Kista
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1949
142 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Novartis Sverige Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
635M
1B
2B
3B
1.7B
2020
1.6B
2021
1.7B
2022
2.0B
2023
2.2B
2024
EBITDA
SEK millions
0M
30M
60M
90M
120M
83M
2020
75M
2021
74M
2022
71M
2023
104M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 652 800
1 646 843
1 743 677
1 976 097
2 209 309
Staff expenses
—
—
—
—
—
EBITDA
83 238
74 660
73 587
70 614
104 321
Depreciation & amort.
−2 987
−2 687
−2 675
−2 505
−2 506
EBIT
80 251
71 973
70 912
68 109
101 815
Net financials
−11 594
−6 343
−9 138
−11 327
−17 957
Profit before tax
73 734
65 630
61 774
56 781
83 857
Tax
−19 343
−11 704
−26 020
−5 005
−14 867
Net profit
54 391
53 926
35 754
51 776
68 990
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
552 631
600 820
699 168
742 443
1 040 617
Equity
110 421
114 347
100 101
131 877
150 868
Long-term debt
0
0
0
0
212 293
Short-term debt
241 854
290 775
324 137
341 152
376 388
Total debt
241 854
290 775
324 137
341 152
588 681
Financial ratios
5-year trend
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
2020
2024
Equity ratio
14.5%
This company
38.2%
Market median
-62% vs market
2020
2024
Return on equity
45.7%
This company
18.4%
Market median
+148% vs market
2020
2024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
2020
2024
Asset turnover
2.12×
This company
1.12×
Market median
+89% vs market
2020
2024
Debt / equity
5.90×
This company
0.62×
Market median
-852% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Novartis Sverige Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
